World Health Organization raises concern about the spread of mosquito-borne Chikungunya virus
GENEVA (REUTERS)The World Health Organization issued an urgent call for action on Tuesday to prevent a repeat of an epidemic of the mosquito-borne chikungunya virus that swept the globe two decades ago, as new outbreaks linked to the Indian Ocean region spread to Europe and other continents.An estimated 5.6 billion people live in areas across 119 countries at risk from the virus, which can cause high fever, joint pain and long-term disability, Diana Rojas Alvarez, a medical officer at the WHO, told reporters in Geneva.'We are seeing history repeating itself,' she said, drawing parallels to the 2004-2005 epidemic, which affected nearly half a million people, primarily in small island territories, before spreading around the world.The current surge began in early 2025, with major outbreaks in the same Indian Ocean islands which were previously hit, including La Reunion, Mayotte and Mauritius.An estimated one-third of La Reunion's population has already been infected, Rojas Alvarez said. The virus is now spreading to countries such as Madagascar, Somalia and Kenya, and has shown epidemic transmission in Southeast Asia, including India.Of particular concern is the increasing number of imported cases and recent local transmission within Europe.There have been approximately 800 imported chikungunya cases in continental France since May 1, Rojas Alvarez said.Twelve local transmission episodes have been detected in several southern French regions, meaning individuals were infected by local mosquitoes without having travelled to endemic areas. A case was also detected last week in Italy.
Chikungunya, for which there is no specific treatment and which is spread primarily by Aedes mosquito species, including the "tiger mosquito" which also transmits dengue, and Zika, can cause rapid and large outbreaks. As the mosquitoes bite in the daytime, prevention is key, through the use of insect repellent and long-sleeved clothing.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Gulf Today
18 hours ago
- Gulf Today
5 years after COVID, pharma shares languish
Global healthcare stocks have not been this cheap in decades and fund inflows into the sector are picking up, yet the shares remain in the doldrums, highlighting uncertainty over drug pricing policies since Donald Trump returned to the White House. Pharma companies' earnings outlook is being obscured by concerns over revived "most-favored-nation" drug pricing rules in the lucrative US market and potential 200% tariffs on pharma imports into the US. Money flooded into drugmakers' shares during the COVID-19 pandemic but more recently there has been an exodus as investors shifted into Big Tech, leaving the sector cheap but unloved, reported Reuters. At 15.9 times forward earnings, healthcare trades 11% below its long-term average and 20% below global equities, its steepest discount in 16 years, just above a record discount in 2009, based on LSEG Datastream data. "We've moved from cautious optimism to cautious pessimism," said Stephanie Aliaga, global market strategist at J.P. Morgan Asset Management in New York. "Valuations have gotten even cheaper, but for a reason," she added, referring to intensifying US policy risks. But some investors are starting to look past the Washington policy fog and at long-term positive drivers, such as aging populations, RNA-based therapeutics, and breakthroughs in weight-loss and diabetes drugs, Reuters reported. Alberto Conca, CIO at Swiss wealth manager LFG+ZEST, has been adding exposure to pharma, biotech and medtech in recent weeks, drawn by strong cash-flow yields and the prospect of US rate cuts boosting this rate-sensitive sector. Interest rate cuts typically support healthcare by lowering R&D funding costs and boosting the value of future cash flows. "These are quality companies with good growth and defensive features being priced as if we're heading into an 'Armageddon scenario', which I believe is unlikely," he said. UK-based M&G Investments has also been selectively adding to healthcare, according to its latest allocation report. Healthcare funds have seen net inflows since 2024, more than reversing the outflows from late 2022 through 2023, fund tracker EPFR data shows. Although year-to-date, inflows total $7.2 billion, down 41% from last year. Innovation is accelerating, pipelines are maturing and M&A is showing signs of picking up — yet stock prices are unmoved. Whether that represents a buying opportunity or a value trap hinges on how and when the policy uncertainty clears, investors said. Historically, healthcare has traded at a modest premium to world stocks, thanks to its defensive profile and steady earnings. But that narrative has unravelled under political pressure from Washington and investors' love of Big Tech. Over the past three years, US healthcare has underperformed the S&P 500 by more than 60 percentage points, making it the worst sectoral performer on Wall Street. Its valuation has deepened to a near-record 27% discount, from parity to the S&P in 2023. "Markets don't like uncertainty, and that shows up in valuations," said Eddie Yoon, healthcare sector leader and portfolio manager at Fidelity Investments in Boston. "Being cheap isn't necessarily a reason to buy. You need a catalyst." For now, that catalyst is elusive. The policy uncertainty makes it difficult to forecast future earnings, he said, though he hopes for more clarity by year-end - potentially also paving the way for more M&A in the industry. Talks with the Trump administration have yet to clarify how and when drug prices will fall, executives from Eli Lilly and Merck said at a May industry conference.
Zawya
a day ago
- Zawya
World Health Organization (WHO) hands over supplies to Al Sabbah Children Hospital, South Sudan's only children hospital
Al Sabbah children hospital is the only tertiary referral children's hospital in South Sudan with a stabilization center receiving children with severe acute malnutrition from all parts of the country. This translates into the high demand for medical supplies and equipment for the hospital to be able to tend to the one thousand children coming to the center each month. Despite the stretch, Al Sabbah children hospital runs with slightly over 100 health workers and still manages to provide clinical training to students from both public and private institutions. The nutrition team of the World Health Organization (WHO) in South Sudan has been a longstanding partner and advocate for the hospital to benefit from technical and logistical support in critical areas. Dr Joseph Elias, the acting Executive Director of Al Sabbah is appreciative of WHO's support: 'We know that the patients exceed the hospital's capacity which affects the access to timely and quality healthcare. Having partners such as WHO supporting Al Sabbah children hospital is a godsend for both the health workers and the families.' said Dr Elias. On 21 July, WHO handed over pediatric beds, mattresses, oxygen concentrators, spare parts, severe acute malnutrition (SAM) kits and pulse oximeters to the management of Al Sabbah children hospital. The medical supplies and equipment were procured with funding from the European Civil Protection and Humanitarian Aid Operations (ECHO). The handover was an emotional moment for the personnel who often have more patients than beds and less supplies than they need to treat them. Betty Achan has been a nutritionist at Al Sabbah children hospital stabilization center for over a decade: 'Look at this beautiful ward. These beds were really needed. Receiving them from WHO was a relief. We have so many children, and it is heartbreaking to tell a family that you have nowhere to put their sick child. Please go be our ambassadors and advocate more. We need more over everything because the demand is so high.' Said Betty. South Sudan faces many challenges, particularly in the health sector, and children are among the most vulnerable. Based on the hospital's monthly pediatric death audits, 50% of deaths occurring at Al Sabbah are recorded at the stabilization center. Over the first quarter of 2025, mortality rates at the center range between 14% and 19%. The main causes of the alarming rates being Malaria, Pneumonia, Sepsis and Acute Watery Diarrhea (AWD) which is particularly dangerous for children due to their smaller and developing bodies making them more susceptible to infections. The supplies from WHO are intended to strengthen the stabilization center and hospital's capacity to respond to the needs of children who walk through Al Sabbah's doors. Dr Humphrey Karamagi, WHO Representative in South Sudan assured the hospital of continued support: 'These supplies are for the children. They are for the mothers who sit anxiously at their bedside. They are for the doctors and nurses who work tirelessly. And they are for a future where every child in South Sudan has the opportunity not just to survive, but to thrive.' Supporting Al Sabbah children hospital is part of WHO's broader commitment to improving maternal, newborn, and child health in South Sudan as well as the country's health priorities. Distributed by APO Group on behalf of World Health Organization (WHO) - South Sudan.
Zawya
2 days ago
- Zawya
Unicef, World Bank join forces with South Africa for pandemic readiness
A mechanism set to support pandemic preparedness in low- and middle-income countries is set to be launched later this week. The Department of Health, in collaboration with the World Health Organisation (WHO), the Food and Agriculture Organisation (FAO), and the United Nations Children's Fund (Unicef), will officially launch the Pandemic Fund. As the project lead for this initiative, the Department of Health aims to strengthen South Africa's capacity to prevent, prepare for, and respond to future pandemics. According to the joint statement, the launch, scheduled for Thursday in Pretoria, represents a significant milestone in global health security efforts. The Pandemic Fund, hosted by the World Bank, is a global financing mechanism that provides catalytic funding to support pandemic preparedness and response in low- and middle-income countries. 'South Africa's engagement through this project reinforces its leadership and commitment to advancing health system resilience,' the statement read. The launch will feature keynote remarks from national and international leaders, the unveiling of South Africa's Pandemic Fund implementation strategy, a panel discussion on pandemic preparedness, and opportunities for media engagement and networking with key stakeholders. The gathering will feature senior officials from various departments, including Health, Agriculture, Land Reform, and Rural Development, as well as Forestry, Fisheries, and the Environment. Representatives from the WHO, Unicef, FAO, the Pandemic Fund Secretariat, development partners, civil society organisations, and the media will also be present. All rights reserved. © 2022. Provided by SyndiGate Media Inc. (
